ASPIRIN GIVEN TWICE DAILY REDUCED THE PLATELET REACTIVITY MORE THAN ONCE DAILY IN PEOPLE WITH TYPE 2 DIABETES WITHOUT CARDIOVASCULAR DISEASE
Huvudupphovsmän: | YiHong, S, Bethel, M, Holman, R, Sourij, H, Harrison, P, Tucker, L, Kennedy, I, White, S, Hill, L, Oulhaj, A, Coleman, R, Hu, D |
---|---|
Materialtyp: | Journal article |
Publicerad: |
2013
|
Liknande verk
Liknande verk
-
Randomized controlled trial comparing impact on platelet reactivity of twice‐daily with once‐daily aspirin in people with type 2 diabetes
av: Bethel, M, et al.
Publicerad: (2016) -
Once- versus twice-daily aspirin treatment in patients with essential thrombocytosis
av: Mads Lamm Larsen, et al.
Publicerad: (2019-04-01) -
Twice-daily versus once-daily lisinopril and losartan for hypertension: Real-world effectiveness and safety.
av: Catherine G Derington, et al.
Publicerad: (2020-01-01) -
Twice-Daily versus Once-Daily Pramipexole Extended Release Dosage Regimens in Parkinson’s Disease
av: Ji Young Yun, et al.
Publicerad: (2017-01-01) -
A randomized trial of once daily versus twice daily dosing of oral iron in CKD
av: Vivek Sood, et al.
Publicerad: (2023-01-01)